— Why it moved

Why NXTC Stock More Than Doubled Premarket Today — July 14, 2026

NextCure, a two-dollar biotech near-shell, announced an all-stock merger with Avere and a $320M raise before the bell — and its 2.26M-share float gapped more than 150% in premarket.

NXTCJul 14, 2026+152% peak
NXTC intraday chart, Jul 14, 2026

What moved NXTC stock

NextCure is a clinical-stage biotech that had spent the last year as a near-shell — a market cap under ten million and a stock scraping two bucks. Before the bell it announced a definitive all-stock merger with privately held Avere Therapeutics, paired with a concurrent $320M private financing to push AVR-001, a once-weekly oral IL-23 receptor antagonist for psoriasis and ulcerative colitis. The combined company will run as Avere Therapeutics and re-list as "AVRX," with the deal expected to close in the second half of 2026.

The mechanics

This is what a hard M&A headline does to a micro-float. With roughly 2.26M shares out and an ~$8M cap, there was almost nothing to buy, so a real merger dropped into a premarket with no liquidity and the price gapped violently. Small cap, tiny float, genuine catalyst: the setup for a triple-digit spike.

NXTC by the numbers

Cap~$8M / float: 2.26M
Day volume~109M (~730x avg)
Prev close$2.18 → +123% to the alert
52w range$1.55–$15.74

The alert window

Stock Pulse flagged it premarket at 6:15 AM at $4.87. The peak, $12.30, printed at 7:15 AM — 60 minutes later. That is a full hour of window, and it was a real one: premarket traded about 54.7M shares before the bell, so the run wasn't a paper print nobody could fill. An hour to work a +152% move.

How NXTC's move ended

It closed at $6.58, up about 35% from the alert but nearly half off the $12.30 high. That gap is the merger-arb math showing up: the terms are fixed and all-stock, so once the arb desks set their price the scarcity premium bled out through the regular session. No revenue, an early-stage asset, and a deal that won't close until late 2026 — the pop was mechanical, not a re-rating.

The tell: a reverse-merger pop on a sub-3-million-share float runs on scarcity, not deal math — once the arb crowd prices the fixed all-stock terms, the premarket spike is the whole trade and the rest is a slow leak.

Get the signal first.

Install free. Real-time small-cap signals on iOS and Android.